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Abstract
Background: Expansion of aquaculture is seriously limited by reductions in fish oil (FO) supply for aquafeeds.
Terrestrial alternatives such as vegetable oils (VO) have been investigated and recently a strategy combining genetic
selection with changes in diet formulations has been proposed to meet growing demands for aquaculture products.
This study investigates the influence of genotype on transcriptomic responses to sustainable feeds in Atlantic salmon.
Results: A microarray analysis was performed to investigate the liver transcriptome of two family groups selected
according to their estimated breeding values (EBVs) for flesh lipid content, ‘Lean’ or ‘Fat’, fed diets containing either FO
or a VO blend. Diet principally affected metabolism genes, mainly of lipid and carbohydrate, followed by immune
response genes. Genotype had a much lower impact on metabolism-related genes and affected mostly signalling
pathways. Replacement of dietary FO by VO caused an up-regulation of long-chain polyunsaturated fatty acid
biosynthesis, but there was a clear genotype effect as fatty acyl elongase (elovl2) was only up-regulated and
desaturases (Δ5 fad and Δ6 fad) showed a higher magnitude of response in Lean fish, which was reflected in liver fatty
acid composition. Fatty acid synthase (FAS) was also up-regulated by VO and the effect was independent of genotype.
Genetic background of the fish clearly affected regulation of lipid metabolism, as PPARa and PPARb were down-
regulated by the VO diet only in Lean fish, while in Fat salmon SREBP-1 expression was up-regulated by VO. In addition,
all three genes had a lower expression in the Lean family group than in the Fat, when fed VO. Differences in muscle
adiposity between family groups may have been caused by higher levels of hepatic fatty acid and glycerophospholipid
synthesis in the Fat fish, as indicated by the expression of FAS, 1-acyl-sn-glycerol-3-phosphate acyltransferase and lipid
phosphate phosphohydrolase 2.
Conclusions: This study has identified metabolic pathways and key regulators that may respond differently to
alternative plant-based feeds depending on genotype. Further studies are required but data suggest that it will be
possible to identify families better adapted to alternative diet formulations that might be appropriate for future
genetic selection programmes.
Background
Fish are highly nutritious components of the human diet.
In addition to providing high quality and easily digested
protein, vitamins and minerals, they are particularly
important in being the main source of essential n-3 long-
chain polyunsaturated fatty acids (LC-PUFA). The bene-
ficial effects of these fatty acids, such as eicosapentaenoic
acid (EPA) and docosahexaenoic acid (DHA), include
prevention of a range of cardiovascular and inflammatory
diseases, and neurological disorders [1]. With catches
from commercial fisheries stagnating since 2001, aqua-
culture is supplying an increasing proportion of fish for
human consumption, estimated at around 50% of total
supply in 2008 [2]. However, the expansion of aquacul-
ture and the demands it makes upon resources provide
many challenges, leading to questions concerning the
sustainability of this activity. In particular, marine and
salmonid aquaculture relies heavily on fish meal (FM)
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any medium, provided the original work is properly cited.and fish oil (FO), obtained from wild fishery stocks, for
the production of fish feeds and around 88.5% of the
total global production of FO is currently used by aqua-
culture [3]. The increasing scarcity of FO supplies will
seriously limit aquaculture growth, and the future of this
activity therefore strongly depends on reducing its reli-
ance on FO by seeking to replace them with alternative,
largely terrestrial, oils. Vegetable oils (VO) represent a
potentially critical resource in this respect. However, VO
lack the n-3 LC-PUFA which are abundant in FO, and
farming fish on diets containing a high proportion of VO
results in lower levels of these omega-3 fatty acids in
flesh, compromising their health-promoting effects to the
human consumer [4].
The use of selective breeding programs to enhance
traits of commercial importance is becoming increasingly
more common in aquaculture [5]. Combining genetic
selection with changes in commercial feed formulations
(i.e., higher levels of inclusion of VO) may be a viable
strategy to meet worldwide demand for farmed fish with-
out compromising animal welfare or nutritional value.
Recently we showed that deposition and/or retention in
flesh of dietary n-3 LC-PUFA, EPA and DHA, is a highly
heritable trait in salmon [6], prompting further interest
in exploring genotype-nutrient interactions. Other recent
work has investigated potential interactions between
genetic selection for body fatness and dietary lipid level
in rainbow trout [7,8], and the effects of FM and/or FO
replacement on the liver transcriptome of both rainbow
trout and Atlantic salmon [9-11]. However, there are few
data on the interaction between genotype and dietary
fatty acid composition. In this respect, microarrays have
great potential for application as hypothesis-generating
tools. The objective of the present study was to investi-
gate nutrient-genotype interactions in two groups of
Atlantic salmon families, Lean and Fat, fed diets where
FO was completely replaced by a VO blend. The knowl-
edge gained concerning how this substitution affects
hepatic metabolism and, furthermore, how these effects
may depend on the genetic background of the fish, not
only informs our understanding of lipid metabolism
more generally but is also highly relevant to the strategy
of genetic selection for families better adapted to alterna-
tive and more sustainable feed formulations in the future.
A previous study has already focused on hepatic choles-
terol and lipoprotein metabolism [12], which was shown
to present a significant diet × genotype interaction, while
here we will present more broadly the effects of the fac-
tors ‘diet’ and ‘genotype’.
Results
Microarray results
Two-way ANOVA of the cDNA microarray dataset
returned a high number of features showing evidence of
differential expression for each factor - 713 for diet and
788 for genotype - and hence a more detailed analysis
was restricted to the top 100 most significant hits for
each factor, which were then categorised according to
function (excluding 33-35% non-annotated features)
(Figure 1). The functional category most affected by diet
was that of metabolism (mainly lipid and carbohydrate
metabolism), while immune response and intracellular
trafficking were also affected. Within lipid metabolism,
the affected genes are involved in PUFA, fatty acid and
cholesterol biosynthesis (fatty acyl desaturases - Δ5f a d
and Δ6 fad, fatty acid synthase - FAS, squalene monoox-
ygenase and possibly cytochrome P450 reductase), gly-
cerophospholipid metabolism (phospholipase D3) and
acylglycerol homeostasis (angiopoietin-like 3). Some
genes related to carbohydrate metabolism, implicated in
glycolysis, glutamine/fructose 6-phosphate and glycerol-
3-phosphate metabolism, such as alpha-enolase, gluta-
mine-fructose-6-phosphate transaminase 1(GFPT1) and
glycerol kinase, respectively, were also identified as
being significantly affected by diet. Genotype had a
lower impact on metabolism-related genes (primarily
Figure 1 Functional categories of genes differentially expressed
in Atlantic salmon liver. The top 100 most significant clones (two-
way ANOVA analysis; p < 0.05) which were differentially expressed
between the two diets (A) and family groups (B) were categorized
according to biological function. Non-annotated clones, those
representing the same gene or with a miscellaneous function (Tables
2 and 3) are not represented.
Morais et al. BMC Genomics 2011, 12:255
http://www.biomedcentral.com/1471-2164/12/255
Page 2 of 17lipid and protein metabolism) and affected mostly genes
involved in signalling. Regarding lipid metabolism, pri-
mary roles of affected genes are in glycerophospholipid
metabolism (N-acylethanolamine-hydrolyzing acid ami-
dase precursor, lipid phosphate phosphohydrolase 2 -
LPP2 and 1-acyl-sn-glycerol-3-phosphate acyltransferase
- AGPAT), fatty acid transport (intestinal fatty acid
binding protein) and lipoprotein metabolism (apolipo-
protein B - ApoB and endothelial lipase - EL). In addi-
tion, both factors had an effect on a relatively high
number of transcription-related genes. Detailed lists of
the top 100 most significant genes for diet and geno-
type, organised by biological function and including the
normalised expression ratio between treatments, are
shown in Tables 1 and 2, respectively. Gene Ontology
enrichment analysis, which enables the identification of
GO terms significantly enriched in the input entity list
when compared to the whole array dataset, was per-
formed for both factors, providing evidence for which
biological processes may be particularly altered in the
experimental conditions being compared. For diet, seven
significant GO terms, all interrelated, were identified:
oxidoreductase activity, stearoyl-CoA 9-desaturase activ-
ity, unsaturated fatty acid biosynthetic and metabolic
processes, very long chain fatty acid (VLCFA) biosyn-
thetic and metabolic processes. This is explained by the
high number of Δ5 fad and Δ6 fad features that were
significantly altered when dietary FO was replaced by
VO (Table 1). In contrast, no GO terms were signifi-
cantly enriched in the genotype list.
RT-qPCR
Quantification of gene expression by RT-qPCR was per-
formed to partially validate the microarray results and to
examine particular genes of interest in detail. The latter
included several fatty acyl desaturase and elongase genes
involved in the LC-PUFA biosynthesis pathway that were
identified by GO analysis as being significantly affected
by diet, as well as peroxisome proliferator-activated
receptors (PPAR) and sterol regulatory element binding
protein 1 (SREBP-1), which have important roles in regu-
lating the expression of multiple lipid metabolism genes
(Table 3). In spite of the generally low fold changes, a
good correspondence in terms of expression ratios or in
the direction of change (up- or down-regulation), was
obtained between the microarray and RT-qPCR results
for most quantified genes, including Δ5f a da n dΔ6f a d ,
FAS and heme oxygenase 1 (HOX) for the factor diet,
and ApoB, LPP2 and AGPAT for the factor genotype
(Tables 1, 2, 3). However, comparison of the microarray
and RT-qPCR expression results show an inverse change
in expression for GFPT1 and glutathione S-transferase A
( G S T )i nr e s p o n s et od i e t ,t h el a t t e ro n l yi nt h eF a t
group, and of EL between family groups, although only
when feeding on FO (where the fold-change in the
microarray was negligible). Nonetheless, a perfect match
was not expected given that RT-qPCR primers were
obtained either from published work (e.g., GST) or, when
available, designed on well characterized sequences such
as GenBank reference sequences or clusters on the gene
index database for Atlantic salmon (ASGI), which do not
necessarily match exactly the clone on the array. In fact,
i nt h ec a s eo fE Lt h e r ei se v i d e n c et h a tt h em i c r o a r r a y
probe has high similarity with multiple EST’sa n dh e n c e
is likely to have resulted in cross-hybridisation [12], while
the reference sequence for GFPT1 and the clone in the
microarray are only 93% identical in the aligned region.
In terms of regulation of gene expression by the factor
diet, the qPCR results confirmed the significant up-regu-
lation of Δ5 fad and Δ6 fad in fish fed VO, with a higher
fold change being measured for Δ6 fad. In addition, the
expression ratio was higher in the Lean family group
than in Fat fish, as had also been indicated in the micro-
array analysis. Of the elongase genes, only elovl2 was sig-
nificantly up-regulated by the VO diet, but just in the
Lean family group. Furthermore, quantification of PPAR
genes revealed that only PPARa was down-regulated sig-
nificantly when salmon were fed the VO diet, but only in
the Lean family group. On the other hand, expression of
SREBP-1 was only significantly affected in Fat fish, being
up-regulated in fish fed the VO diet. Other genes which
were significantly and consistently regulated were FAS
and EL (both up-regulated when VO replaced FO in the
diet), while GST, HOX and AGPAT only showed signifi-
cant regulation in Fat fish. Finally, comparison between
the two family groups showed a significantly lower
expression of Δ5f a d ,Δ6f a d ,P P A R a, PPARb,S R E B P - 1
and GST in the Lean group but only when fish were fed
FO, in the case of fads, or when fed the VO diet, in the
case of PPARs, SREBP-1 and GST. In addition, FAS was
also significantly down-regulated in the Lean group, inde-
pendent of diet.
Liver fatty acid composition
Fatty acid analysis of liver showed significant differences
in all fatty acid classes related mostly to diet but also to
genotype (except for total n-3 PUFA and total PUFA)
(Table 4). The percentage of total n-6 PUFA (reflecting
mainly 18:2n-6) was significantly increased when VO
replaced FO in the diet. Levels of total n-3 PUFA were,
on the other hand, significantly higher in the FO treat-
ments independent of genotype. For EPA and DHA
there was a significant diet × genotype interaction,
resulting from the fact that, when comparing Fat and
Lean fish, higher levels of these LC-PUFA were found in
the Fat family group when fed the FO diet but the
inverse was observed when the same fish were fed the
VO diet.
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between diets
Accession or probe number Gene VO/FO ANOVA p-value
Lean Fat
Metabolism
Lipid metabolism
can_D6D_S1B04 Delta-6 fatty acyl desaturase 2.8 1.9 <0.0001
can_D6D_S1B03 Delta-6 fatty acyl desaturase 2.1 1.4 <0.0001
can_D5D_S1B01 Delta-5 fatty acyl desaturase 2.3 1.5 <0.0001
can_D6O_S1B06 Delta-6 fatty acyl desaturase 2.0 1.4 <0.0001
CK887422 Delta-6 fatty acyl desaturase 2.0 1.8 <0.0001
EG647320 Delta-6 fatty acyl desaturase 1.8 1.4 0.0001
CK876943 Fatty acid synthase 1.4 1.6 0.0002
can_D5D_S1B02 Delta-5 fatty acyl desaturase 2.1 1.2 0.0003
CK894344 Phospholipase D3 - 1.1 - 1.2 0.0006
EG647463 Cytochrome P450 reductase - 1.4 - 1.1 0.0017
liv_lrr_01F07 Angiopoietin-like 3 1.2 1.4 0.0020
can_D5O_S1B05 Delta-6 fatty acyl desaturase 1.5 1.2 0.0045
CK879648 Squalene monooxygenase 1.9 1.1 0.0058
Protein and amino acid metabolism
CK893821 Sequestosome 1or ubiquitin-binding protein P62 - 1.3 - 1.1 0.0022
CK884400 Kynureninase (L-kynurenine hydrolase) 1.3 1.2 0.0065
Carbohydrate metabolism
int_oss_T4F08 Alpha-enolase putative - 1.2 - 1.0 0.0007
liv_lrr_01A06 Glutamine-fructose-6-phosphate transaminase 1 1.2 1.8 0.0032
CO470771 Glycerol kinase 1.1 1.1 0.0062
Xenobiotic and oxidant metabolism
AJ425332 Thioredoxin domain-containing protein 8 - 1.3 - 1.3 0.0024
EG355339 Glutathione S-transferase A - 1.4 - 1.4 0.0036
Transport/intracellular trafficking
CK886667 Na/K ATPase 1.5 1.1 <0.0001
CN181143 Coatomer subunit alpha 1.2 1.4 0.0004
DW588711 Synaptic vesicle glycoprotein 2B 1.1 1.1 0.0004
CK894482 Taurine transporter - 1.3 - 1.3 0.0019
CK887866 ABC-type branched-chain amino acid transport systems ATPase component 1.2 1.1 0.0022
CO470399 Sodium/potassium-transporting - 1.2 - 1.2 0.0044
EG647422 Transferrin - 1.2 - 1.1 0.0047
EG648286 ATP-binding cassette sub-family B member 10, mitochondrial 1.2 1.3 0.0055
AM083913 Chromatin modifying protein 2a - 1.3 - 1.2 0.0068
Regulation of transcription
CK894063 Zinc finger protein 183 - 1.5 - 1.3 0.0003
CK890154 Butyrate response factor 2 1.5 1.1 0.0043
EG648112 Retrovirus-related Pol polyprotein 1.1 1.3 0.0046
CK885196 CCAAT/enhancer binding protein delta1 1.2 1.2 0.0052
CK890573 MADS box protein AP1b 1.2 1.2 0.0053
CK883722 Y-box binding protein 1.1 1.3 0.0067
Translation
AM402452 Phenylalanyl-tRNA synthetase, alpha subunit 1.4 1.9 0.0022
Signalling/Signal transduction
CK886572 GSK-3-binding protein 1.9 1.0 0.0002
CK892148 Growth factor receptor-bound protein 7 - 1.5 - 1.1 0.0028
ova_opk_09K06 Phosphoinositide 3-protein kinase - 1.1 - 1.3 0.0031
CK873849 Receptor-type tyrosine-protein phosphatase beta precursor - 1.1 - 1.1 0.0036
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between diets (Continued)
DW590775 Myozenin-1 1.6 1.5 0.0055
Immune response
EG647383 Human leukocyte antigen (HLA) class II histocompatibility 1.1 1.2 0.0008
AM402762 Complement component C8 alpha chain 1.3 1.7 0.0018
EG649410 D-dopachrome tautomerase 1.4 1.1 0.0019
AJ425750 Non-histone chromosomal protein H6 1.1 1.3 0.0024
CK884265 Ganglioside GM2 activator 1.3 1.1 0.0030
AM402841 Complement component C8 alpha chain 1.5 2.1 0.0032
CK886548 T cell receptor (TCR)-alpha/delta locus - 1.2 - 1.0 0.0041
spl_sts_18A08 Leukotriene B4 receptor 1 putative - 1.4 - 1.1 0.0047
CK880083 Interleukin-15 precursor 1.1 1.3 0.0067
AJ425732 CD97 antigen isoform 2 1.2 1.1 0.0066
Miscellaneous and unknown function
CK897269 Biotinidase precursor 1.3 1.7 0.0002
AM402518 Biotinidase 1.4 1.9 0.0006
CK894173 EFHD2 (EF hand domain containing2) 1.2 1.1 0.0007
kid_cki_A1E04 S100-A1 calcium binding 1.4 1.1 0.0009
CO469646 beta B3-crystallin - 1.1 - 1.0 0.0012
CO469710 Transmembrane protein 30A - 1.1 - 1.2 0.0019
AJ425502 Heme oxygenase 1 - 2.7 - 1.7 0.0024
CK885237 EF-hand domain-containing protein D2 1.1 1.1 0.0026
AJ425502 Heme oxygenase 1 - 2.6 - 1.4 0.0037
DW588567 S100 calcium binding protein beta subunit 1.1 1.1 0.0042
CK897725 Type-1 growth hormone 1.1 1.1 0.0053
BM414485 Apoptosis-inducing factor mitochondrion-associated inducer 1.5 1.4 0.0054
BM414504 Syndecan 2 - 1.2 - 1.1 0.0061
BI468143 Anaphase-promoting complex subunit CDC26 - 1.3 - 1.3 0.0064/p>
CK885116 17-beta hydroxysteroid dehydrogenase 13 - 1.1 - 1.4 0.0065
Annotated features (65% of all clones) are arranged by categories of biological function and, within these, by decreasing significance (assessed by two-way
ANOVA). Also indicated are the GenBank accession numbers for each clone (or, when not available, the probe number is given instead) and the expression ratio
between fish fed VO and those fed FO, for each genotype (Lean and Fat).
Table 2 Liver transcripts corresponding to the top 100 most significant features exhibiting differential expression
between family groups
Accession or probe number Gene Lean/Fat ANOVA p-value
FO VO
Metabolism
Lipid metabolism
CK889835 N-acylethanolamine-hydrolyzing acid amidase precursor - 1.4 - 1.2 0.0001
can_Apo_S1A12 Apolipoprotein B - 1.4 - 1.1 0.0014
BM414066 Endothelial lipase precursor - 1.1 - 1.6 0.0015
CK898924 Lipid phosphate phosphohydrolase 2 - 1.2 - 1.2 0.0017
AJ425826 Intestinal fatty acid binding protein 1.1 1.2 0.0032
CO470953 1-acyl-sn-glycerol-3-phosphate acyltransferase - 1.1 - 1.3 0.0040
Energy metabolism/generation of precursor metabolites
EG649459 NADH dehydrogenase (ubiquinone) 1 beta subcomplex 1.2 1.2 0.0009
Protein and amino acid metabolism
CK900470 26S protease regulatory subunit 7 - 1.1 - 1.2 0.0020
mus_mfo_15B08 Proteasome subunit alpha type-1 1.2 1.1 0.0021
EG648604 Serine protease-like protein 1.0 1.4 0.0023
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CO470297 Transmembrane protease, serine 2 - 1.2 - 1.1 0.0032
DW592216 Ubiquitin carboxyl-terminal hydrolase 5 - 1.1 - 1.1 0.0040
Transport/intracellular trafficking
CK886667 Na/K ATPase 1.1 1.6 <0.0001
CK884193 Polycystin-2 (Polycystic kidney disease 2 protein homolog) 1.1 1.2 0.0002
CK890974 Mitochondrial solute carrier family 25 member 25 - 1.2 - 2.2 0.0002
CK896189 Mitochondrial solute carrier family 25 member 25 - 1.3 - 2.3 0.0002
CK880187 ATP-binding cassette sub-family B member 8, mitochondrial - 1.3 - 1.1 0.0011
Regulation of transcription
CK881770 Hematopoietically-expressed homeobox protein - 1.1 - 1.6 0.0001
CK888834 BTEB transcription factor - 1.4 - 1.5 0.0002
CK895950 Transcription factor CP2-like - 1.2 - 1.6 0.0010
CK884953 Nuclear transcription factor Y subunit beta - 1.2 - 1.1 0.0015
CK888548 Rev protein - Human immunodeficiency virus 1 - 1.5 - 1.0 0.0019
CK883410 Retinoic acid receptor gamma (nuclear receptor) - 1.1 - 1.1 0.0020
int_rpk_78B12 Sp3 transcription factor - 1.1 - 1.4 0.0035
CK876044 Homeobox protein HoxB13 - 1.2 - 1.2 0.0041
DW589427 Cullin-associated and neddylation-dissociated 1 (CAND1) 1.4 1.1 0.0044
Translation
AJ424434 Ribosome production factor 1 1.1 1.2 0.0002
gil_oss_G6P11 40S ribosomal protein S23 1.3 1.3 0.0008
EG648403 60S ribosomal protein L7a 1.2 1.2 0.0013
CK893177 40S ribosomal protein S26 1.1 1.2 0.0013
DW591137 40S ribosomal protein S3a - 1.2 - 1.1 0.0024
EG647811 60S ribosomal protein L7 1.1 1.1 0.0026
EG648956 Eukaryotic translation initiation factor 1A 1.1 1.1 0.0033
AJ424851 40S ribosomal protein S18 1.2 1.2 0.0034
Signalling/Signal transduction
CK884714 14-3-3 protein epsilon 1.1 1.1 0.0003
EG648400 Guanine nucleotide binding protein (G protein) - 1.2 - 1.2 0.0004
CK888542 Insulin-like growth factor binding protein 1 - 1.2 - 2.5 0.0008
CK886572 GSK-3-binding protein putative - 1.1 1.8 0.0009
CK877143 Calpain-1 - 1.1 - 1.4 0.0010
EG648399 PTC7 protein phosphatase homolog - 1.2 - 1.1 0.0016
EG648333 Stathmin 1.1 1.2 0.0018
CK898969 G-protein coupled receptor 37 - 1.1 - 1.1 0.0019
DW589782 Amyloid beta (A4) precursor-like protein 1.1 1.2 0.0034
CK898590 Mitogen-activated protein kinase kinase 4 - 1.0 - 1.2 0.0035
CK897997 Calpastatin - 1.1 - 1.1 0.0039
AJ424385 Protein tyrosine phosphatase, receptor-type, zeta1 - 1.1 - 1.2 0.0041
Structural proteins
AJ425204 Tropomyosin-1 alpha (muscle contraction) - 1.1 - 1.2 0.0031
Immune response
CK886548 T cell receptor (TCR)-alpha/delta locus - 1.1 - 1.2 0.0005
CK894741 Complement factor D (adapsin) - 1.1 - 1.2 0.0007
AM042439 Major histocompatibility complex (MHC) class I antigene - 1.3 - 1.4 0.0014
kid_cki_A1G02 Interferon-inducible protein - 1.2 - 1.4 0.0015
CO471904 Major histocompatability complex (MHCI) - 1.1 - 1.2 0.0019
CK894557 Major histocompatability complex (MHCI) - 1.2 - 1.1 0.0023
AM042249 Major histocompatability complex (MHCI) - 1.1 - 1.2 0.0025
bra_opk_01B08 Scavenger receptor cysteine-rich gene - 1.3 - 1.6 0.0029
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I nt h ep r e s e n ts t u d yw ea n a l y s e dt h ee f f e c t so fd i e t s
containing high levels of plant proteins and with com-
plete replacement of FO by VO on the liver transcrip-
tome of Atlantic salmon, which is the primary metabolic
organ of fish, as well as the influence of genotype on
these responses. Here we focus on the separate effects
of diet and genotype given that interactions, indicating
pathways that were differentially affected by diet
depending on the genetic background of the fish, were
discussed in detail previously [12].
A common methodological difficulty in this type of
nutritional experiment is that effects are typically quite
subtle although physiological and metabolic pathways can
be impacted by even small fold changes in gene expres-
sion. This has been demonstrated by several studies
Table 2 Liver transcripts corresponding to the top 100 most significant features exhibiting differential expression
between family groups (Continued)
CO469739 T-cell receptor(TCR)-alpha/delta locus - 1.1 - 1.1 0.0030
AJ424124 Major histocompatibility complex (MHC class I) - 1.2 - 1.1 0.0037
hrt_opk_07E23 Interferon alpha 1-like - 1.1 - 1.1 0.0041
Miscellaneous and unknown function
CK898014 Protein fuzzy homolog - 1.1 - 1.2 0.0002
kid_cki_A2A05 Cyclin B2 - 1.3 - 1.4 0.0006
EG647643 Purine nucleoside phosphorylase - 1.1 - 2.0 0.0010
liv_lrr_07B04 Nuclear protein 1 - 1.1 - 2.1 0.0028
AM402622 Non-POU domain containing, octamer-binding - 1.7 - 1.4 0.0029
EG648147 Adhesion-regulating molecule 1 - 1.2 - 1.1 0.0037
BM414485 Apoptosis-inducing factor mitochondrion-associated inducer 1.4 1.5 0.0038
DW589496 Cyclin-dependent kinase inhibitor - 1.2 - 1.3 0.0044
Annotated features (67% of all clones) are arranged by categories of biological function and, within these, by decreasing significance (assessed by two-way
ANOVA). Also indicated are the GenBank accession numbers for each clone (or, when not available, the probe number is given instead) and the expression ratio
between Lean and Fat fish fed either FO or VO.
Table 3 Relative expression of genes assayed by RT-qPCR in liver of Atlantic salmon
VO/FO Lean/Fat
Lean Fat FO VO
Genes Ratio p-value Ratio p-value Ratio p-value Ratio p-value
Δ5 fad 3.95 0.001 2.04 0.002 -2.33 0.009 -1.20 0.317
Δ6 fad_a 8.27 0.000 4.52 0.004 -1.85 0.049 -1.02 0.942
elovl5a 1.18 0.505 -1.03 0.817 -1.18 0.420 1.03 0.908
elovl5b 1.57 0.184 1.05 0.758 -1.25 0.471 1.19 0.416
elovl2 2.35 0.025 -1.04 0.841 -1.56 0.098 1.58 0.112
FAS 1.76 0.005 2.11 0.003 -1.72 0.001 -2.04 0.011
PPARa -2.22 0.000 1.10 0.643 -1.16 0.358 -2.86 0.001
PPARb -1.92 0.161 1.56 0.169 1.24 0.659 -2.44 0.002
PPARg -1.10 0.828 -1.67 0.251 -2.00 0.214 -1.32 0.229
SREBP-1 -1.16 0.761 3.32 0.004 1.82 0.332 -2.13 0.022
GST -1.18 0.412 1.40 0.010 1.29 0.210 -1.28 0.028
HOX -2.69 0.132 -1.82 0.013 1.83 0.271 1.24 0.120
GFPT1 -1.33 0.244 -1.65 0.090 -1.18 0.619 1.05 0.783
ApoB 1.40 0.443 1.84 0.152 -1.15 0.791 -1.52 0.076
EL 3.52 0.034 8.57 0.002 1.38 0.494 -1.75 0.115
LPP2 -1.33 0.506 -1.31 0.606 -1.22 0.754 -1.25 0.516
AGPAT 1.40 0.375 1.42 0.041 -1.05 0.906 -1.07 0.574
Values are normalised (by cofilin-2) gene expression ratios between fish fed VO in relation to FO for each family group or of Lean fish in relation to the Fat group
when fed either one of the diets. Values in bold are significantly different, at p < 0.05 (REST 2008).
fad: fatty acyl desaturase (Δ5a n dΔ6); elovl: elongase (three different transcripts); FAS: Fatty acid synthase; PPARs; peroxisome proliferator-activated receptors
(three isoforms); SREBP-1: Sterol regulatory element binding protein-1; GST: glutathione S-transferase A; HOX: heme oxygenase 1; GFPT1: glutamine-fructose-6-
phosphate transaminase 1; ApoB: apolipoprotein B; EL: endothelial lipase; LPP2: lipid phosphate phosphohydrolase 2; AGPAT: 1-acyl-sn-glycerol-3-phosphate
acyltransferase.
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Page 7 of 17[7,9,11] and by previously reported data from the present
study showing that low fold changes in gene expression
were associated with biochemical differences in tissue lipid
class and apolipoprotein composition [12]. Furthermore,
low fold changes observed in this study were generally cor-
roborated by RT-qPCR, even if the low expression ratios
meant that differences were not always significant. It
should also be noted that a total match between the
microarray and the RT-qPCR results is not expected due
to the approach taken to design RT-qPCR primers on bet-
ter annotated reference sequences rather than on less well
characterized microarray clones. In view of the whole gen-
ome duplication event that occurred in salmonid fishes
[13], transcriptomic and gene expression studies are often
more challenging due to the presence of duplicated and
highly similar genes whose transcripts might be differen-
tially regulated, as observed previously for lipoprotein
lipase [12]. Therefore, collectively, and in conjunction with
previous studies, data obtained in the present microarray
study enabled identification of pathways that may be dif-
ferentially affected by both dietary oil composition and
genetic background related to flesh adiposity.
Effects of diet on lipid metabolism
Within the list of genes affected by diet, those involved in
fatty acyl desaturation were prominent, leading to the
identification, through GO enrichment analysis, of
several terms related to LC-PUFA biosynthetic and meta-
bolic processes. The up-regulation of Δ5 fad and Δ6f a d
in both family groups when dietary FO was replaced by
VO was confirmed by RT-qPCR. Several studies have
previously demonstrated up-regulation of genes involved
in LC-PUFA biosynthesis in salmon when FO is replaced
by VO [10,14,15]. RT-qPCR also confirmed previous
work showing that elovl2 is responsive to dietary n-3 LC-
PUFA levels [15], being the only elongase whose expres-
sion was up-regulated when FO was replaced by VO.
However, a significant effect was only observed in the
Lean family group. In addition, both microarray and RT-
qPCR analyses indicated that the up-regulation of Δ5f a d
and Δ6 fad showed a considerably higher fold-change in
t h eL e a nf i s h ,d u em a i n l yt ol o w e rb a s a le x p r e s s i o no f
fads in Lean salmon, compared to Fat, when fed FO.
These results indicate that the activity of this biosynthetic
pathway may be dependent on the genetics of the fish,
with different family groups showing differences in the
magnitude of response. The liver fatty acid composition
revealed that differences in EPA and DHA levels between
fish fed either diet were smaller in the Lean fish, due to
higher n-3 LC-PUFA in fish fed VO and lower n-3 LC-
PUFA in fish fed FO, compared to the equivalent treat-
m e n t si nt h eF a tg r o u p .I na d d i t i o n ,i n t e r m e d i a t e si nt h e
biosynthetic pathway, such as 20:4n-3 and 22:5n-3,
tended to be present at higher levels in the Lean family
Table 4 Liver fatty acid composition (percentage of total fatty acids) of Atlantic salmon Lean and Fat family groups
fed diets containing either FO or VO
Parameters FO VO ANOVA
Fat Lean Fat Lean Diet Genotype Diet×Gen
Fatty acid
Total saturated 25.8 ± 0.8 22.1 ± 1.5 19.1 ± 1.0 18.3 ± 1.0 <0.0001 <0.0001 0.0044
Total monoenes 23.8 ± 1.3 31.1 ± 2.5 40.8 ± 3.3 39.0 ± 2.5 <0.0001 0.0141 0.0002
18:2n-6 2.9 ± 0.1 3.0 ± 0.3 10.1 ± 0.2 10.4 ± 0.2 <0.0001 0.0317 ns
18:3n-6 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.1 0.1 ± 0.0 ns ns ns
20:2n-6 0.5 ± 0.0 0.7 ± 0.0 1.6 ± 0.2 1.9 ± 0.1 <0.0001 <0.0001 ns
20:3n-6 0.4 ± 0.0 0.4 ± 0.0 1.3 ± 0.1 1.4 ± 0.1 <0.0001 ns ns
20:4n-6 2.2 ± 0.2 1.9 ± 0.2 1.2 ± 0.1 1.4 ± 0.1 <0.0001 ns 0.0009
22:5n-6 0.2 ± 0.0 0.2 ± 0.1 0.1 ± 0.0 0.1 ± 0.0 <0.0001 ns ns
Total n-6 PUFA 6.3 ± 0.3 6.3 ± 0.4 14.4 ± 0.3 15.3 ± 0.3 <0.0001 0.0031 0.0031
18:3n-3 1.0 ± 0.0 1.1 ± 0.2 4.3 ± 0.2 4.7 ± 0.2 <0.0001 0.0021 0.0466
18:4n-3 0.4 ± 0.1 0.4 ± 0.1 0.3 ± 0.0 0.3 ± 0.1 0.0104 ns ns
20:3n-3 0.2 ± 0.0 0.3 ± 0.0 0.7 ± 0.1 0.7 ± 0.3 <0.0001 ns ns
20:4n-3 1.6 ± 0.1 2.3 ± 0.3 1.1 ± 0.1 1.3 ± 0.1 <0.0001 <0.0001 0.0021
20:5n-3 8.6 ± 0.3 8.2 ± 0.4 4.7 ± 0.4 5.2 ± 0.4 <0.0001 ns 0.0085
22:5n-3 3.6 ± 0.2 4.4 ± 0.3 1.9 ± 0.2 2.1 ± 0.1 <0.0001 <0.0001 0.0025
22:6n-3 28.6 ± 1.0 23.7 ± 1.9 12.6 ± 1.5 13.1 ± 1.1 <0.0001 0.0011 0.0002
Total n-3 PUFA 44.1 ± 1.1 40.5 ± 1.5 25.7 ± 2.4 27.4 ± 1.4 <0.0001 ns 0.0009
Total PUFA 50.4 ± 1.2 46.8 ± 1.5 40.2 ± 2.6 42.8 ± 1.6 <0.0001 ns 0.0004
Results are means ± SD (n = 6) and p-values of two-way ANOVA are presented for factors ‘diet’, ‘genotype’ and interaction between both factors. ns, not
significantly different (p > 0.05).
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of mRNA of LC-PUFA biosynthesis genes, which have
been shown to correlate with the enzymatic activity of
this pathway in salmon [16,17], were reflected in bio-
chemical composition.
Another lipid metabolism gene significantly affected by
diet was FAS, which was up-regulated in both family
groups when fed VO. A well demonstrated effect of diet-
ary FO supplementation in mammals is hypotriglyceride-
mia, resulting from a coordinated effect of n-3 LC-PUFA
in suppressing hepatic lipogenesis and enhancing fatty
acid oxidation in liver and muscle [18]. Furthermore, this
gene also appears to be regulated at a pre-translational
level and hence changes in FAS transcription are likely to
result in important effects in terms of enzyme activity
[19]. Similar mechanisms are believed to operate in fish
but, although reduced hepatic lipogenic activity modu-
lated by LC-PUFA has been demonstrated in vitro [20], a
direct relationship with dietary FO and VO has not
always been clear in vivo [21,22]. The regulation of FAS
in response to FO replacement by VO did not show an
interaction with the flesh leanness/fatness phenotype in
this study, as might have been expected. This was
because genotype also had a significant effect, with the
Lean group having lower levels of FAS expression than
the Fat fish, with a similar fold-change in both diets.
Regulation of lipid metabolism is complex and con-
trolled by several transcription factors and nuclear recep-
tors, including PPARs and SREBPs. SREBP-1c is a major
regulator of lipogenesis in mammals [18]. Here we mea-
sured the expression of SREBP-1 as there is no evidence
for the existence of alternatively spliced isoforms in sal-
mon, and primers corresponded to an identical region in
mammalian SREBP-1a and SREBP-1c [23]. Our results
agree with Minghetti et al. [23], who showed SREBP-1
was increased by cholesterol and decreased by EPA and
DHA supplementation in a salmon cell line, denoting a
similar nutritional regulation to mammals [18]. However,
t h e r ew a sac l e a rg e n e t i ce f f e c ta se x p r e s s i o no fS R E B P - 1
was 3-fold higher in Fat salmon fed VO, containing lower
EPA, DHA and cholesterol, than in fish fed FO, whereas
no regulation was observed in the Lean group.
PPARs have been less studied in fish than in mammals
but present evidence suggests PPARa and PPARb have
similar ligands and functions to their mammalian homo-
logues, while PPARg may present some functional differ-
ences [24,25]. LC-PUFA are well recognised enhancers of
PPARa activity in fish, and while the response of PPARb
to LC-PUFA might be variable between fish species, an
enhancement of activity in sea bass, plaice and sea bream
[24-26] and of expression in Atlantic salmon [27] has
been observed. In addition, and unlike rodents, PPARa
and PPARb have a similar pattern of expression in
response to fasting and feeding in sea bream liver,
indicating that they may be regulated similarly [25]. In
the present study, PPARa was down-regulated when VO
replaced FO but only in the Lean family group and,
although not statistically significant, PPARb showed a
similar trend, suggesting similar transcriptional regula-
tion of these nuclear receptors by dietary fatty acid com-
position. These results thus indicate that the genetic
background of the fish might affect PPAR transcriptional
responses to LC-PUFA. In contrast, no nutritional regu-
lation was observed for PPARg transcription in liver, in
accordance with previous studies in fish, including sal-
mon, and its predominant role in adipocytes [24,28].
The hypotriglyceridemic effects of n-3 LC-PUFA in
mammals involve activation of PPARa, leading to up-reg-
ulation of b-oxidation genes (including carnitine palmi-
toyltransferase I - CPT1 and acyl-CoA oxidase - ACO)
and suppression of SREBP-1c transcription that down-reg-
ulates lipogenic enzymes [29,30]. As previously reported,
FAS expression was up-regulated in both family groups
fed the VO diet but neither CPT1 nor ACO expression,
was affected [12]. As elovl2 expression was only altered in
the Lean fish and both Δ5 fad and Δ6 fad showed greater
up-regulation in Lean salmon fed VO, we may speculate
that PPARa (and potentially also PPARb) expression may
be involved in down-regulation of LC-PUFA biosynthesis.
Paradoxically, fatty acyl desaturases are regulated by both
SREBPs and PPARs in mammals [31]. In addition, PPARa
agonists regulate the transcriptional activity of elongases
in rat, although only elovl5 and not elovl2 [32]. However,
in mammals, PPARa ligands induce the transcription of
elongases and desaturases while we observed an up-regu-
lation of elovl2 and a stronger stimulation of Δ5 fad and
Δ6 fad transcription when PPARa expression was lower.
In the rat and human Δ6 fad gene promoters, both PUFA
and PPARa response regions have been identified which
suppress and induce, respectively, Δ6 fad expression [33].
The molecular mechanisms of transcriptional regulation
of these genes are complex and will require further investi-
gation in salmon [34]. In contrast, target genes of SREBP-1
remain elusive and, although it may regulate FAS expres-
sion [23], this was only observed in Fat fish whereas, in the
Lean group, another mechanism is required to explain up-
regulation of FAS in VO-fed fish as expression of SREBP-
1 was unaffected. Nonetheless, the action of SREBP-1 is
under the regulation of liver X receptor (LXR) and these
complex pathways have only recently started to be investi-
gated in fish [23].
Another gene affected by diet was squalene epoxidase
(SQLE), which was up-regulated by VO but only mark-
edly in the Lean family group. This enzyme catalyses the
first oxygenation step in sterol biosynthesis, a pathway
identified earlier as presenting a diet × genotype interac-
tion [12]. In contrast, cytochrome P450 reductase (CPR)
was down-regulated in salmon fed VO, particularly in
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donor for several oxygenase enzymes, such as cyto-
chrome P450 (involved in drug and xenobiotic metabo-
lism, and sterol and bile acid synthesis), HOX and
cytochrome b5 (which supports both sterol and LC-
PUFA biosynthesis pathways). In addition, it has key
roles in the biosynthesis of several signalling factors and
the regulation of oxidative response genes [reviewed by
[35]]. CPR is transcriptionally regulated by PPARa in
m o u s ea n d ,g i v e nt h ec o m p a r a b l eP P A R a and CPR
expression in Lean salmon fed VO, similar regulation
likely occurs in salmon. However, changes in CPR
expression can be related to several processes that were
affected by FO replacement. Thus, CPR expression could
be linked to changes in both cholesterol and LC-PUFA
biosynthesis, both more marked in Lean fish, although
this is unlikely because VO induced up-regulation of
these pathways. A more likely association is with cell oxi-
dant metabolism, also suggested by the microarray
results as being possibly down-regulated in VO-fed fish.
In particular, down-regulation of HOX in salmon fed
VO, more marked for Lean fish correlating with CPR
expression, might be an indication of this.
Effect of diet on carbohydrate and intermediate
metabolism
Within the metabolism genes that were identified by the
microarray analysis as being significantly affected by diet-
ary oil substitution, a few relate to carbohydrate metabo-
lism, particularly glucose and intermediary metabolism.
Given that similar effects were observed in previous sal-
monid studies, and that a few signal transduction genes
present in the list of diet significant effects are also
potentially implicated in these pathways, these results
warrant further discussion, even if the observed fold
changes were low. An association between lipid and car-
bohydrate metabolism in salmon is not surprising given
that the pathways of lipogenesis, lipolysis, glycolysis, glu-
coneogenesis and pentose phosphate shunt are all inter-
related in the regulation of body energy homeostasis. In
mammals, the role of LC-PUFA as “fuel partitioners”
involves both directing fatty acids away from anabolic
and towards catabolic routes as well as enhancing glucose
flux to glycogen, mediated by effects on SREBP-1 and
transcription factors that regulate key genes of lipid
metabolism and glycolysis [30]. Similar mechanisms may
operate in fish but differences are likely given that carni-
vorous fish like salmon have low capacity to use carbohy-
drate and appear to show features of glucose intolerance
[36,37]. Nonetheless, dietary n-3/n-6 ratio has been
shown to influence mRNA levels of the glucose transpor-
ter GLUT4 in Atlantic salmon muscle, with some reflec-
tion in plasma glucose [38]. In addition to a decreased
hexokinase and phosphoenolpyruvate carboxykinase
expression, complete replacement of FM and FO by
vegetable alternatives in rainbow trout resulted in a
slightly increased expression of glycerol kinase, as
observed here [11]. This enzyme is at the intersection of
lipid-carbohydrate metabolism and over-expression of
this gene in human muscle and rat hepatoma cells
resulted in higher TAG synthesis and up-regulation of
the pentose phosphate pathway providing reducing
power for lipogenesis [39]. Panserat et al. [11] hypothe-
sised that the up-regulation of glycerol kinase may be
related to higher lipid biosynthesis in liver when trout
were fed plant-based diets. Similarly, our results, asso-
ciated with the observed changes in FAS mRNA when
VO replaced FO, suggest a possible relationship with
lipogenesis. Also possibly related with this was the up-
regulation of two different biotinidase clones with the
potential to increase availability of substrates for FAS
and/or gluconeogenesis in VO-fed fish. This gene,
besides being involved in the regulation of gene expres-
sion, including genes of glucose metabolism, codes for an
enzyme that recycles biotin, which is a co-factor for sev-
eral carboxylases responsible for production of substrates
for lipogenesis and gluconeogenesis [40].
Another gene affected by diet was alpha-enolase, which
was slightly down regulated in Lean fish fed VO. A similar
effect was observed in liver of salmon fed rapeseed oil in
comparison to FO [9]. This glycolytic enzyme participates
in the conversion of glucose to pyruvate, a key intermedi-
ate at the intersection of multiple metabolic pathways,
including lipogenesis. Thus, this might result in lower
levels of pyruvate for conversion to acetyl-CoA in VO-fed
fish. This result does not necessarily conflict with an
increase in lipogenesis given that, in fish, carbon skeletons
for de novo fatty acid production are mainly derived from
amino acid catabolism rather than from carbohydrates,
whose main contribution towards lipogenesis is to supply
NADPH via the pentose-phosphate pathway [37].
Finally, a few signalling genes that were significantly
affected by diet might also have an effect on glucose meta-
bolism, assuming that similar cascades exist in fish. One of
these is phosphoinositide 3-protein kinase (PI3K), which
mediates insulin’s effects on glucose, lipid and protein
metabolism, and that was significantly down regulated in
VO-fed fish. Among other roles, it regulates glucose cellu-
lar uptake in mammals, recruiting GLUT4 transporters to
the cell surface [41]. In addition, it is found upstream of a
signal transduction cascade regulating glycogen synthesis
through glycogen synthase, by inactivating glycogen
synthase kinase-3 (GSK3) [41,42]. In our study, expression
of GSK3-binding protein (GBP) was significantly increased
in VO-fed Lean fish. GBP is a protein that blocks GSK3,
which in turn inactivates glycogen synthase [43]. Hence, it
is possible that the oil composition of the diet might also
affect glucose metabolism and glycogen storage.
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Increased oxidative stress associated with the consumption
of FO has been typically reported in fish and mammals
[27,44,45]. Accordingly, genes related to oxidant metabo-
lism were found in the significant list for diet. A thiore-
doxin domain-containing protein, possessing an
antioxidant role [46], and GST, which detoxifies peroxi-
dised lipids and xenobiotics [47], were down-regulated in
salmon fed VO, consistent with the higher auto-oxidative
potential of LC-PUFA in FO. However, quantification of
GST by RT-qPCR was not consistent with the microarray
result, although the possibility exists that different GST
genes with differential regulation exist in salmon and this
requires clarification. In addition, the observed down-regu-
lation of HOX in VO-fed fish, validated by RT-qPCR,
might be related to a decrease in oxidative stress in these
fish. This enzyme catalyses the degradation of heme and
can be induced by oxidative stress [48] and may be
increased during pro-inflammatory states, being thought to
increase resistance to oxidative injury and ameliorate
inflammation [49]. The n-3 LC-PUFA in FO have impor-
tant anti-inflammatory actions in mammals [50], which
does not correlate with the expression of HOX and its
putative role in inflammation in this case. Inflammation is
an important mechanism in immune defence but, in fish,
the demonstrated effects of LC-PUFA on immune and
inflammatory mechanisms have been inconsistent [45].
However, a recent study has clearly shown an effect of diet-
ary oil composition on the progression of a myxosporean
parasite infection in Gilthead sea bream, with fish fed the
VO diet showing higher signs of the disease and faster
course of infection in comparison with those on a FO diet
[51]. On the other hand, the synthesis of pro-inflammatory
eicosanoids was increased in the intestine of salmon fed
vegetable-based diets in response to acute stress [52]. In the
present study immune response was the second highest
category of genes affected by diet, after metabolism.
Whether this is due to the potential anti-inflammatory role
of dietary FO or whether VO diets can have detrimental
health effects is not clear as the fold-changes were subtle,
as expected in unchallenged animals. Nonetheless, the
majority of genes related to processes of both innate and
adaptive immunity were up-regulated in fish fed VO. Only
T-cell and leukotriene B4 (LTB4)r e c e p t o r s ,t h a ta r e
reduced after antigen and LTB4 exposure, respectively, and,
in the case of LTB4 receptor, increased after EPA adminis-
tration [53-55], were down-regulated in salmon fed VO.
Differences in gene expression between Lean and Fat
genotypes
Muscle adiposity is a trait of great importance in animal
production, aquaculture included, and hence physiologi-
cal changes induced by genetic selection for this pheno-
type have been examined in various animals, including
rainbow trout [7,8]. In the present study the main differ-
ences between family groups were associated with signal
transduction pathways, followed by metabolism. Only a
small number of lipid metabolism genes varied in rela-
tion to muscle adiposity, as reported previously in rain-
bow trout, where the main differences were related to
lipogenesis and mitochondrial oxidative metabolism
[7,8]. In our study glycerophospholipid metabolism may
have been down-regulated in the Lean family group
through AGPAT and LPP2, two enzymes acting conse-
cutively on de novo TAG and phospholipid biosynthesis
[56,57]. Quantification of AGPAT and LPP2 expression
by RT-qPCR confirmed this down-regulation but fold-
changes were too subtle to be significant. AGPAT con-
verts lysophosphatidic acid into phosphatidic acid (PA),
while LPP2 then catalyzes the conversion of PA to dia-
cylglycerol. All these molecules can function as second
messengers and are involved in the regulation of multi-
ple signalling pathways. Therefore, down-regulation of
this pathway in the Lean group has the potential to
lower lipid biosynthesis, at least partly explaining the
flesh lipid phenotype, but may also alter levels of lipid
signalling molecules. On the other hand, differences in
muscle adiposity might also be caused by higher hepatic
“de novo” fatty acid synthesis in the Fat family group, as
indicated by the expression of FAS. In a previous study,
no differences were found in the expression of ACO
and CPT1, which suggested that the phenotypes could
not be explained by differences in b-oxidation [12]. By
contrast, in rainbow trout Fat and Lean families, b-oxi-
dation and mitochondrial oxidative metabolism, but not
lipogenesis, were affected by genetic selection [7],
although another study using the same trout lines sug-
gested differences related to lipogenesis rather than fatty
acid oxidation [8]. Thus, both metabolic processes are
likely involved and discrepancies in the data are likely
due to lack of methodological sensitivity to detect the
small fold-changes that are possibly characteristic of
these biological processes and typical in this type of
experiment.
PPARa,P P A R b and SREBP-1 were also regulated in
response to genotype, being down-regulated in Lean fish,
but only when fed the VO diet. In cobia, Rachycentron
canadum, a negative correlation was found between
PPARa mRNA levels in liver and body lipid deposition
[58]. Furthermore, PPARb appears to play a similar role
in fish to that in mammals, as a ubiquitous regulator of
fat burning and with a role in energy mobilisation during
early development [24,25]. Therefore, both PPARa and
PPARb m i g h th a v ear o l ei nt h ec o n t r o lo fa d i p o g e n e s i s
in fish and it may be the case that, similarly to chickens
[59], Fat salmon might have higher lipid turnover than
their Lean counterparts when fed a diet that predisposes
for hepatic fat deposition, even though the end result is
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Collin et al. [59] suggested that a fat chicken family is
better “equipped” to deal with higher circulating levels of
TAG when fed a high fat diet, compared to lean chicken.
O nt h eo t h e rh a n d ,w eo b s e r v e dad i r e c tr e l a t i o n s h i p
between SREBP-1 and FAS expression in the Fat family
group in response to diet, as well as in VO-fed fish in
response to genotype. It thus appears that SREBP-1 may
be partly responsible for higher lipogenesis in Fat fish,
compared to Lean, when fed VO.
Conclusions
This study has enabled the identification of metabolic
pathways and key regulators that may respond differently
to more sustainable diets, in which FO is replaced by VO,
depending on genotype, thus confirming the potential of
microarrays as hypothesis-generating tools, even in these
nutritional studies where changes in gene expression are
quite subtle. Collectively, and in conjunction with previous
s t u d i e s ,t h ed a t ai n d i c a t et h a t dietary lipid composition
may potentially affect glucose, glycogen storage and inter-
mediary metabolism, in addition to lipogenesis, supporting
a role for LC-PUFA in “fuel partitioning” in fish as well as
in mammals. Therefore, more integrative studies investi-
gating the effects of dietary VO on energy homeostasis are
required. However, important genotype-related differences
may also exist in the regulation of metabolism. In terms of
lipid metabolism, expression of LC-PUFA and lipid bio-
synthesis genes, as well as of key regulator transcriptional
factors, was differentially affected by diet depending on the
genetic background of the fish. Although further studies
are required, the present data indicate that it will be possi-
ble to identify families better adapted to alternative diet
formulations that might be appropriate for future genetic
selection programmes.
Methods
Feeding trial and sampling
A dietary trial was conducted using two genetically char-
acterised and contrasting groups of farmed Atlantic sal-
mon post-smolts, comprising full-sib families selected
from the Landcatch Natural Selection Ltd (LNS) breed-
ing program (Argyll, Scotland). The choice of the two
family groups was based on estimated breeding values
(EBVs) of the parents for high or low flesh adiposity,
assessed by Torry Fatmeter (Distell Industries, West
Lothian, UK), a trait that was found to have a heritability
ranging from 0.17 to 0.39 in this dataset. The two groups
were created from four unrelated full-sib families; two
families from the extreme lower end of the EBV distribu-
tion for flesh lipid content (’Lean’) and two families from
the extreme upper end of the distribution (’Fat’). The
average EBV for the lipid content of the two Fat families
was 2.00 percentage units higher than that of the two
selected Lean families, representing a standardised selec-
tion differential of 2.33 standard deviations. Assessment
of the flesh and viscera lipid content at the end of the
feeding trial confirmed differences in adiposity between
the two genotypes, in spite of an interaction with diet
being also found [12].
T w ot h o u s a n df i s ho fe a c hg r o u pw e r es t o c k e di n t o
e i g h t1 2×5m
3 n e tp e n sa tt h eA r d n i s hF i s hT r i a l sU n i t
(Marine Harvest Scotland, Lochailort, Highland; 500 fish
pen
-1). Duplicate pens from each group of fish were fed
one of two experimental diets (Skretting ARC, Stavanger,
Norway) containing 32-25% fish meal, 40-45% plant
meals and 27.5-30% oil supplied either as northern fish
oil (FO) or as a vegetable oil (VO) blend comprising
rapeseed, palm and Camelina oils in a ratio of 5:3:2 [12].
Diets were formulated to fully satisfy the nutritional
requirements of salmonid fish [61] and contained similar
levels of PUFA (around 31%) but different n-3 and n-6
PUFA contents, 25.3% and 4.6% in the FO diet and 13.4%
and 17.1% in the VO diet, respectively. Further details
including full diet formulations, proximate and fatty acid
compositions of the feeds can be found in Bell et al. [60].
After 55 weeks on the experimental diets 25 fish were
sampled per pen. The fish were killed by a blow to the
head following anaesthesia using MS222, 24 h after the
last meal. Samples of liver were immediately frozen on
dry ice and stored at -70°C for molecular and fatty acid
analyses.
RNA extraction and purification
Liver tissue (0.2 g) from six individuals per experimental
group was rapidly homogenised in 2 mL of TRI Reagent
(Ambion, Applied Biosystems, Warrington, U.K.) using an
Ultra-Turrax tissue disrupter (Fisher Scientific, Loughbor-
ough, U.K.) and stored at -70°C. Total RNA was later iso-
lated, following manufacturer’si n s t r u c t i o n s ,a n dR N A
quality (integrity and purity) and quantity was assessed by
gel electrophoresis and spectrophotometry (NanoDrop
ND-1000, Thermo Scientific, Wilmington, U.S.A.). One
hundred micrograms of total RNA from each individual
sample was further cleaned by mini spin-column purifica-
tion (RNeasy Mini Kit, Qiagen, Crawley, UK), and then re-
quantified and quality assessed as above.
Microarray hybridizations and image analysis
The TRAITS/SGP (v.2.1) salmon 17 k cDNA microar-
ray, described in detail by Taggart et al. [10], was used
in this experiment (ArrayExpress accession: A-MEXP-
1930). A dual-label experimental design was employed
for the microarray hybridisations. Each experimental
sample was competitively hybridised against a common
pooled-reference sample, which comprised equal
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permits valid statistical comparisons across all treat-
ments to be made. The entire experiment comprised 24
hybridisations - 2 genotypes (Lean/Fat) × 2 diets (FO/
VO) × 6 biological replicates.
An indirect labelling methodology was employed in
preparing the microarray targets. Antisense amplified
RNA (aRNA) was produced from 500 ng of purified total
RNA per sample using the Amino Allyl MessageAmpTM
II aRNA Amplification Kit (Ambion, Applied Biosys-
tems), as per manufacturer’s instructions, followed
by Cy3 or Cy5 fluor incorporation mediated by a dye-
coupling reaction, as previously described in detail [12].
Experimental samples and the pooled reference sample
(batch reaction) were labelled with Cy3 and Cy5 dye sus-
pension stocks (PA23001 or PA25001, GE HealthCare,
Little Chalfont, UK), respectively. Unincorporated dye
was removed by column purification (Illustra AutoSeq
G-50 spin columns; GE Healthcare). Dye incorporation
and aRNA yield were quantified by spectrophotometry
(NanoDrop ND-1000) and further quality controlled by
separating 0.4 μL of the sample through a thin mini-agar-
ose gel and visualising products on a fluorescence scan-
ner (Typhoon Trio, GE Healthcare).
Microarray hybridisations were performed in a Lucidea
semi-automated system (GE Healthcare), without a pre-
hybridisation step. For hybridisation of each array, each
labelled biological replicate and corresponding pooled
reference (40 pmol each dye, c. 150 ng aRNA) were com-
bined and added to the hybridisation solution, compris-
ing 185 μL 0.7X UltraHyb buffer (Ambion), 20 μLp o l y
(A) at l0 mg/mL (Sigma-Aldrich, Dorset, UK), 10 μL her-
ring sperm at c. 10 mg/mL (Sigma-Aldrich) and 10 μL
ultra pure BSA at 10 mg/mL (Sigma-Aldrich), as detailed
previously [12]. Two post-hybridisation automatic washes
followed by six manual washes to a final stringency of
0.1× SSC (EasyDipTM Slide staining system; Canemco
Inc., Quebec, Canada) were performed before scanning.
Scanning was performed at 10 μm resolution using an
Axon GenePix 4200AL Scanner (MDS Analytical Technol-
ogies, Wokingham, Berkshire, U.K.) with laser power con-
stant (80%) and “auto PMT” e n a b l e dt oa d j u s tP M Tf o r
each channel such that less than 0.1% of features were
saturated and that the mean intensity ratio of the Cy3 and
Cy5 signals was close to one. BlueFuse software (Blue-
Gnome, Cambridge, U.K.) was then used to identify fea-
tures and extract fluorescence intensity values from the
resultant TIF images. Following a manual spot removal
procedure and fusion of duplicate spot data (BlueFuse pro-
prietary algorithm), the resulting fluorescence intensity
data and quality annotations for the 17,102 gene features,
were exported into the GeneSpring GX version 10.0.2 ana-
lysis platform (Agilent Technologies, Wokingham, Berk-
shire, U.K.) after undergoing a block Lowess normalisation.
Data transformation and quality filtering were then per-
formed and all control features were excluded from subse-
quent analyses [12]. This returned a list of 14,772 genes
eligible for statistical analysis. Experimental annotation
complied fully with minimum information about a micro-
array experiment (MIAME) guidelines [62]. The experi-
mental hybridisations and further methodological details
are archived on the EBI ArrayExpress database (http://
www.ebi.ac.uk/arrayexpress/) under accession number
E-TABM-1089.
RT-qPCR
Expression of selected genes was determined by reverse
transcription quantitative real time PCR (RT-qPCR).
Details on the target qPCR primer sequences are given in
Table 5. In addition, amplification of three potential refer-
ence genes - cofilin-2, elongation factor-1a (elf-1a)a n db-
actin - was performed. However, only cofilin-2 expression
proved to be sufficiently stable across treatments for nor-
malisation of the results. Cofilin-2 had been established in
a previous salmon cDNA microarray study as a suitable
reference gene on the basis of constant expression
between FO and VO based feeds over a wide range of
time points (’unidentified liver EST’,[ 1 0 ] ) .
For RT-qPCR, 1 μg of column-purified total RNA per
sample was reverse transcribed into cDNA using the
VersoTM cDNA kit (ABgene, Surrey, U.K.), following
manufacturer’s instructions, using a mixture of random
hexamers (400 ng/μL )a n da n c h o r e do l i g o - d T( 5 0 0n g /
μL) at 3:1 (v/v). Negative controls (containing no
enzyme) were performed to check for genomic DNA
contamination. A similar amount of cDNA was pooled
from all samples and the remaining cDNA was then
diluted 20-fold with water. RT-qPCR analysis used rela-
tive quantification with the amplification efficiency of
the primer pairs being assessed by serial dilutions of the
cDNA pool. qPCR amplifications were carried out in
duplicate (Quantica, Techne, Cambridge, U.K.) in a final
volume of 20 μL containing either 5 μLo r2μL( f o rt h e
reference genes and HOX) diluted (1/20) cDNA, 0.5 μM
of each primer and 10 μLA b s o l u t e T MQ P C RS Y B R
®
Green mix (ABgene). Amplifications were carried out
with a systematic negative control (NTC-non template
control). The qPCR profiles contained an initial activa-
tion step at 95°C for 15 min, followed by 30 to 40 cycles
(depending on target): 15 s at 95°C, 15 s at the specific
primer pair annealing temperature (Ta; Table 5) and 15
s at 72°C. After the amplification phase, a melt curve of
0.5°C increments from 75°C to 90°C was performed,
enabling confirmation of the amplification of a single
product in each reaction. RT-qPCR product sizes were
checked by agarose gel electrophoresis and the identity
of amplicons of newly designed primers (FAS, GFPT1,
HOX, LPP2 and AGPAT) was confirmed by sequencing.
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Total lipids from six fish per treatment were extracted and
determined gravimetrically from 1-2 g of liver by Ultra
Turrax homogenisation in 20 volumes of chloroform/
methanol (2:1 v/v) [63]. Fatty acid methyl esters (FAME)
were prepared by acid-catalysed transesterification of total
lipids [64]. Following purification, FAME were separated
a n dq u a n t i f i e db yg a s - l i q u i dc h r o m a t o g r a p h yu s i n ga
Thermo Fisher Trace GC 2000 (Thermo Fisher, Hemel
Hempstead, UK) equipped with a fused silica capillary
column (ZB wax, 30 m×0.32 mmi.d.; Phenomenex,
Macclesfield, UK) with hydrogen as carrier gas and using
Table 5 Primers used for RT-qPCR analyses
Transcript Primer sequence (5’-3’) Fragment Ta Efficiency Accession No. Source
Δ5fad GTGAATGGGGATCCATAGCA 192 bp 56°C 0.995 AF478472
1 [66]
AAACGAACGGACAACCAGA
Δ6fad_a CCCCAGACGTTTGTGTCAG 181 bp 56°C 0.944 AY458652
1 [66]
CCTGGATTGTTGCTTTGGAT
elovl5a ACAAGACAGGAATCTCTTTCAGATTAA 137 bp 60°C 0.925 AY170327
1 [15]
TCTGGGGTTACTGTGCTATAGTGTAC
elovl5b ACAAAAAGCCATGTTTATCTGAAAGA 141 bp 60°C 0.940 DW546112
1 [15]
CACAGCCCCAGAGACCCACTT
elovl2 CGGGTACAAAATGTGCTGGT 145 bp 60°C 0.960 TC91192
2 [15]
TCTGTTTGCCGATAGCCATT
FAS GTGCCCACTGAATACCATCC 212 bp 60°C 0.995 CK876943
1 New design
ATGAACCATTAGGCGGACAG
PPARa TCCTGGTGGCCTACGGATC 111 bp 60°C 0.986 DQ294237
1 [67]
CGTTGAATTTCATGGCGAACT
PPARb GAGACGGTCAGGGAGCTCAC 151 bp 60°C 0.992 AJ416953
1 [67]
CCAGCAACCCGTCCTTGTT
PPARg CATTGTCAGCCTGTCCAGAC 144 bp 60°C 0.999 AJ416951
1 [67]
TTGCAGCCCTCACAGACATG
SREBP-1 GCCATGCGCAGGTTGTTTCTTCA 151 bp 63°C 0.942 TC148424
2 [20]
TCTGGCCAGGACGCATCTCACACT
GST ATTTTGGGACGGGCTGACA 81 bp 60°C 0.989 GE619558
1 [68]
CCTGGTGCTCTGCTCCAGTT
HOX GTCAACGCATCACCCTTCTT 206 bp 60°C 0.997 BT046987
1 New design
ATGGGGTCCTTCATCCTCTT
GFPT1 GTGGTTTGGCAGACCTCCTA 177 bp 60°C 0.999 NM_001140266
1 New design
TGTACGGTGCCATCTTTCAA
ApoB AGCCTTCGATGCTGTCGGCCA 153 bp 60°C 1.000 TC79364
2 [12]
AGGAGCACAGGCAGGGTGGTT
EL CCGGTGCTGCTGGAGGAAGC 378 bp 60°C 0.962 NM_001140535
1 [12]
CGACATGCAGGTCATCGGT
LPP2 TCCGGAAGAACTCGCAATAC 174 bp 60°C 0.949 NM_001140716
1 New design
ACATCACGTCCACCAAGACA
AGPAT GAGAGCCAGAGGTTGAGGTG 245 bp 60°C 0.941 NM_001141753
1 New design
CAGAGTGAAGGCGATGTGAA
Reference genes:
elf-1a CTGCCCCTCCAGGACGTTTACAA 175 bp 60°C 0.986 AF321836
1 [15]
CACCGGGCATAGCCGATTCC
b-actin ACATCAAGGAGAAGCTGTGC 141 bp 56°C 0.968 AF012125
1 [15]
GACAACGGAACCTCTCGTTA
Cofilin-2 AGCCTATGACCAACCCACTG 224 bp 60°C 0.999 TC63899
2 [15]
TGTTCACAGCTCGTTTACCG
1 GenBank (http://www.ncbi.nlm.nih.gov/)
2 Atlantic salmon Gene Index (http://compbio.dfci.harvard.edu/tgi/)
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Page 14 of 17on-column injection. The temperature gradient was from
50 to 150°C at 40°C/min and then to 195°C at 1.5°C/min
and finally to 220°C at 2°C/min. Individual methyl esters
were identified by comparison with known standards.
Data were collected and processed using the Chromcard
for Windows (version 2.00) computer package (Thermo-
quest Italia S.p.A., Milan, Italy).
Statistical analysis
Microarray hybridisation data were analysed in Gene-
Spring GX version 10.0.2 (Agilent Technologies) by two-
way ANOVA, which examined the explanatory power of
the variables ‘diet’ and ‘genotype’ (diet×genotype interac-
tion presented in [12]), followed by Gene Ontology (GO)
enrichment analysis, at a significance level of 0.05. No
multiple test correction was employed as previous ana-
lyses, confirmed by RT-qPCR, indicate that such correc-
tions are over-conservative for this type of data [14]. Gene
expression results assessed by RT-qPCR were analysed by
the ΔΔCt method using the relative expression software
tool (REST 2008, http://www.gene-quantification.info/),
employing a pair wise fixed reallocation randomisation
test (10,000 randomisations) with efficiency correction
[65], to determine the statistical significance of expression
ratios between two treatments. Finally, significant differ-
ences in liver fatty acid composition were determined by
means of two-way ANOVA, at a significance level of p <
0.05, using the Graphpad Prism™ (version 4.0) statistical
package (Graphpad Software, San Diego, CA).
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